Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HCA efficiency

S B Heymsfield, L J Aronne, G L Blackburn

    Diabetes, Obesity & Metabolism
    |October 14, 2004
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Liraglutide and cardiovascular outcomes in adults with overweight or obesity: A post hoc analysis from SCALE randomized controlled trials.

    Diabetes, obesity & metabolism·2017
    Same author

    Metformin: an Old Therapy that Deserves a New Indication for the Treatment of Obesity.

    Current atherosclerosis reports·2016
    Same author

    Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels.

    Journal of internal medicine·2013
    Same author

    The neurocognitive connection between physical activity and eating behaviour.

    Obesity reviews : an official journal of the International Association for the Study of Obesity·2011
    Same author

    New drug targets for the treatment of obesity.

    Clinical pharmacology and therapeutics·2011
    Same author

    Day/night variations of high-molecular-weight adiponectin and lipocalin-2 in healthy men studied under fed and fasted conditions.

    Diabetologia·2010
    Same journal

    Relationship Between hsCRP, Glycaemic Control and Response to Sotagliflozin in Type 1 Diabetes: A Post Hoc Analysis of the inTandem3 Trial.

    Diabetes, obesity & metabolism·2026
    Same journal

    Early Weight Regain After GLP-1 Receptor Agonist Discontinuation: Mechanisms and Implications for Treatment De-Escalation Strategies.

    Diabetes, obesity & metabolism·2026
    Same journal

    First-Line Dapagliflozin, Metformin, or Combination Therapy in Type 2 Diabetes: Vascular and Molecular Outcomes of a Randomised Controlled Trial.

    Diabetes, obesity & metabolism·2026
    Same journal

    Trends in Prevalence of Diabetes, Pre-Diabetes, and Cardiometabolic Risk Factor Control Among U.S. Adults, 2013-2023.

    Diabetes, obesity & metabolism·2026
    Same journal

    Metabolic Risk-Attributable Dementia Burden: A Life-Course and Cautious Attribution Perspective.

    Diabetes, obesity & metabolism·2026
    Same journal

    A Highly Powered Large Outcomes Randomised Controlled Trial Will Usually, but Not Always, Have Balanced Groups at Baseline.

    Diabetes, obesity & metabolism·2026
    See all related articles